
Thomas Smith
Stock Analyst at Leerink Partners
(4.99)
# 39
Out of 5,184 analysts
705
Total ratings
54%
Success rate
44.2%
Average return
Main Sectors:
Stocks Rated by Thomas Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVMN Evommune | Reiterated: Buy | $22 | $7.04 | +212.50% | 4 | Nov 16, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | $30 | $11.07 | +171.00% | 35 | Nov 16, 2026 | |
| EQ Equillium | Reiterated: Buy | $6 | $1.06 | +466.04% | 37 | Nov 13, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $26 | $9.08 | +186.34% | 17 | Nov 13, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $11 → $5 | $0.9305 | +437.35% | 2 | Nov 9, 2026 | |
| XFOR X4 Pharmaceuticals | Reiterated: Buy | $12 | $3.00 | +300.00% | 2 | Nov 5, 2026 | |
| IVA Inventiva | Reiterated: Buy | $12 | $3.14 | +282.17% | 3 | Oct 29, 2026 | |
| IRON Disc Medicine | Rated: Buy | $100 → $130 | $75.14 | +73.01% | 29 | Oct 27, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,065 → $1,115 | $925.70 | +20.45% | 37 | Oct 9, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $70 → $88 | $27.42 | +220.93% | 42 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $106 → $128 | $93.47 | +36.94% | 2 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $23 | $11.08 | +107.58% | 53 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.33 | +651.88% | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $6.76 | +462.13% | 1 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.19 | - | 8 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.14 | - | 17 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $3.96 | +708.08% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $29.96 | +66.89% | 39 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $50 | $31.77 | +57.38% | 37 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $5.45 | +560.55% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.59 | - | 20 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $32 | $4.26 | +651.17% | 18 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | krย 102.00 | krย 45.14 | +125.96% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $24.77 | n/a | 38 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.81 | n/a | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.44 | n/a | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $115 | $73.20 | n/a | 17 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $379.10 | n/a | 39 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.78 | n/a | 34 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.34 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $14.93 | n/a | 16 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $6.99 | n/a | 28 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $13.35 | n/a | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 | $115.31 | n/a | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.85 | n/a | 25 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $0.5951 | n/a | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.75 | n/a | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2 | $23.22 | n/a | 16 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 5,312p | 114p | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $21 | $7.05 | n/a | 1 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $6 | $1.71 | n/a | 1 | Sep 8, 2017 |
Evommune
Nov 16, 2026
Reiterated: Buy
Price Target: $22
Current: $7.04
Upside: +212.50%
MoonLake Immunotherapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $30
Current: $11.07
Upside: +171.00%
Equillium
Nov 13, 2026
Reiterated: Buy
Price Target: $6
Current: $1.06
Upside: +466.04%
Sagimet Biosciences
Nov 13, 2026
Reiterated: Buy
Price Target: $26
Current: $9.08
Upside: +186.34%
Zura Bio
Nov 9, 2026
Reiterated: Buy
Price Target: $11 → $5
Current: $0.9305
Upside: +437.35%
X4 Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $12
Current: $3.00
Upside: +300.00%
Inventiva
Oct 29, 2026
Reiterated: Buy
Price Target: $12
Current: $3.14
Upside: +282.17%
Disc Medicine
Oct 27, 2026
Rated: Buy
Price Target: $100 → $130
Current: $75.14
Upside: +73.01%
argenx SE
Oct 9, 2026
Reiterated: Buy
Price Target: $1,065 → $1,115
Current: $925.70
Upside: +20.45%
Celldex Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $70 → $88
Current: $27.42
Upside: +220.93%
Sep 10, 2026
Rated: Buy
Price Target: $106 → $128
Current: $93.47
Upside: +36.94%
Aug 4, 2026
Reiterated: Buy
Price Target: $35 → $23
Current: $11.08
Upside: +107.58%
Jul 28, 2026
Reiterated: Buy
Price Target: $10
Current: $1.33
Upside: +651.88%
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $6.76
Upside: +462.13%
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.19
Upside: -
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.14
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $3.96
Upside: +708.08%
Apr 6, 2026
Reiterated: Buy
Price Target: $50
Current: $29.96
Upside: +66.89%
Apr 2, 2026
Reiterated: Buy
Price Target: $52 → $50
Current: $31.77
Upside: +57.38%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $5.45
Upside: +560.55%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.59
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $25 → $32
Current: $4.26
Upside: +651.17%
Nov 26, 2025
Initiated Coverage: Buy
Price Target: krย 102.00
Current: krย 45.14
Upside: +125.96%
Oct 23, 2025
Reiterated: Buy
Price Target: $118
Current: $24.77
Upside: n/a
Oct 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.81
Upside: n/a
Oct 15, 2025
Reiterated: Buy
Price Target: $7
Current: $3.44
Upside: n/a
Oct 8, 2025
Reiterated: Buy
Price Target: $104 → $115
Current: $73.20
Upside: n/a
Aug 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $379.10
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $8
Current: $1.78
Upside: n/a
Apr 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.34
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $58
Current: $14.93
Upside: n/a
Aug 8, 2024
Reiterated: Hold
Price Target: $5
Current: $6.99
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $6
Current: $13.35
Upside: n/a
Aug 7, 2024
Reiterated: Hold
Price Target: $33
Current: $115.31
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $7
Current: $3.85
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $46
Current: $0.5951
Upside: n/a
Mar 15, 2024
Reiterated: Buy
Price Target: n/a
Current: $10.75
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: $13 → $2
Current: $23.22
Upside: n/a
Aug 8, 2022
Reiterated: Buy
Price Target: 5,312p
Current: 114p
Upside: n/a
Jan 17, 2019
Initiated Coverage: Hold
Price Target: $21
Current: $7.05
Upside: n/a
Sep 8, 2017
Initiated Coverage: Hold
Price Target: $6
Current: $1.71
Upside: n/a